GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCHW) » Definitions » Insider Ownership

Envoy Medical (Envoy Medical) Insider Ownership : 0.00 % (As of Jun. 09, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Envoy Medical's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Envoy Medical's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Envoy Medical's Float Percentage Of Total Shares Outstanding is N/A.


Envoy Medical Insider Ownership Historical Data

The historical data trend for Envoy Medical's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical Insider Ownership Chart

Envoy Medical Annual Data
Trend Dec21 Dec22 Dec23
Insider Ownership
- - -

Envoy Medical Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Insider Ownership Get a 7-Day Free Trial Premium Member Only - - - - -

Envoy Medical Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Envoy Medical (Envoy Medical) Business Description

Traded in Other Exchanges
Address
4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.